In euglycemic diabetic ketoacidosis, how should insulin and dextrose be administered?

Euglycemic DKA Management: Insulin and Dextrose Administration

In euglycemic DKA, dextrose-containing fluids must be started alongside insulin infusion from the very beginning of treatment, not after glucose drops—this is the critical difference from traditional DKA management. 1

Key Management Principles

Insulin Administration

• Start fixed-rate intravenous insulin infusion at 0.1 units/kg/h (or 0.05 units/kg/h for moderate-severe cases) 1
• Do NOT adjust insulin based on glucose levels as you would in hyperglycemic DKA—the goal is to suppress ketogenesis, not lower glucose 2, 3
• Continue insulin infusion until ketoacidosis resolves (pH >7.3, bicarbonate >15-18 mEq/L, anion gap closure) 1

Dextrose Administration: The Critical Difference

Because glucose is already normal or only mildly elevated (<200-250 mg/dL), dextrose-containing fluids (typically 5% or 10% dextrose) must be initiated concurrently with insulin at treatment onset. 1, 4, 5, 3

This is explicitly stated in the 2025 ADA guidelines: "In euglycemic DKA, dextrose needs to be started alongside 0.9% NaCl/crystalloid at the start of the insulin treatment" 1

Glucose Targets During Treatment

• Maintain glucose between 150-200 mg/dL until DKA resolution 1
• Titrate dextrose infusion rate (not insulin) to maintain this target 2, 3
• If glucose drops below 150 mg/dL, increase dextrose concentration or infusion rate 3

Common Pitfalls to Avoid

The Delayed Dextrose Error

Never wait for glucose to drop before starting dextrose—this is the most dangerous mistake in euglycemic DKA management. Traditional DKA protocols that add dextrose only when glucose falls to 200-250 mg/dL will cause severe hypoglycemia and fail to provide adequate substrate for ketoacidosis resolution 5, 3, 6

The Insulin Withholding Error

Some clinicians mistakenly withhold or minimize insulin because glucose is normal. This perpetuates ketogenesis and prolongs acidosis. Adequate insulin (typically 0.1 units/kg/h) is essential to suppress ketone production, regardless of glucose level 2, 3, 6

The Insufficient Glucose Supplementation Error

Case reports demonstrate that inadequate dextrose administration during euglycemic DKA treatment results in persistent ketoacidosis despite normal glucose—a "euglycemic DKA-like state" that only resolves with appropriate glucose supplementation 6

Practical Algorithm

1. Confirm diagnosis: High anion gap metabolic acidosis + elevated ketones (blood β-hydroxybutyrate preferred) + glucose <200-250 mg/dL 3, 7

2. Start simultaneously:

   • IV insulin infusion: 0.1 units/kg/h
   • IV fluids: 0.9% NaCl/crystalloid PLUS 5-10% dextrose 1, 4, 3

3. Titrate dextrose (not insulin) to maintain glucose 150-200 mg/dL 2, 3

4. Monitor closely: Glucose, electrolytes, pH, anion gap every 2-4 hours 1

5. Potassium replacement: Essential—give 20-40 mEq/L in each liter of IV fluid to maintain K+ 4-5 mEq/L 1

6. Continue until resolution: pH >7.3, bicarbonate >15-18 mEq/L, anion gap normalized 1

Special Considerations

This condition is increasingly common with SGLT2 inhibitor use, pregnancy, ketogenic diets, and fasting states 2, 4, 5, 7. The absence of significant hyperglycemia often delays diagnosis—maintain high clinical suspicion in any diabetic patient with unexplained high anion gap metabolic acidosis, even with normal glucose 3, 7.

The modified DKA protocol for euglycemic cases has been formally implemented in ICU settings specifically to address the unique challenge of providing adequate insulin for ketoacidosis resolution while preventing hypoglycemia through concurrent dextrose administration 2.